Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.On December 2006 its developer GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
This page contains content from the copyrighted Wikipedia article "Brecanavir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.